Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin

被引:23
作者
Higaki, K
Nakayama, K
Suyama, T
Amnuaikit, C
Ogawara, K
Kimura, T [1 ]
机构
[1] Okayama Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Okayama 7008530, Japan
[2] Prince Songkla Univ, Fac Pharmaceut Sci, Dept Pharmaceut Technol, Songkhla 90112, Thailand
关键词
direct penetration; skin blood flow; local therapeutics; transdermal absorption; topical application;
D O I
10.1016/j.ijpharm.2004.09.025
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this work was to investigate the effect of blood flow in the skin on the direct penetration of topically applied drugs into the muscular layer, and to show that the skin blood flow could also be one of the important factors determining the direct penetration of drugs to the muscular layer. In vivo percutaneous absorption study was performed for antipyrine, salicylic acid or diclofenac by using rats with tape-stripped skin. Phenylephrine, which is well known to reduce the local blood flow by vasoconstrictor action, was topically applied to decrease the local blood flow in the skin. The concentrations of drugs in viable skin and muscle, and the local blood flow in the skin under the applied and the contralateral sites were determined to evaluate the effect of the local blood flow on the delivery of topically applied drugs into the muscular layer. Dose dependency for the effect of phenylephrine was, first of all, investigated for antipyrine in the range from 0.4 to 10 mumol. The distribution of antipyrine into the viable skin and muscular layer 2 h after topical application significantly increased, but the effect of phenylephrine was saturated around 2 mumol and the dose-dependent profiles for both tissues were almost superimposed. On the other hand, the fraction dose absorbed, plasma concentration and concentrations in viable skin and muscular layer under the contralateral site showed the decreasing tendency and the saturation of the effect around 2 mumol. To confirm the effect of phenylephrine on the local blood flow in the skin, the skin blood flow was measured 2 h after topical application of 2 mumoI phenylephrine, and the significant decrease in the blood flow was recognized. In vivo percutaneous absorption studies were performed for salicylic acid and diclofenac, too. Extensive enhancement of penetration into the viable skin and muscular layer was observed for both drugs, although total absorption from the donor cell showed the decreasing tendency. In conclusion, direct penetration of drugs applied topically is enhanced by reducing the local blood flow in the skin, which would be a possible approach to improve the local delivery of drugs applied topically. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:227 / 233
页数:7
相关论文
共 20 条
[1]   INVIVO EVALUATION OF SIGNAL PROCESSORS FOR LASER DOPPLER TISSUE FLOWMETERS [J].
AHN, H ;
JOHANSSON, K ;
LUNDGREN, O ;
NILSSON, GE .
MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING, 1987, 25 (02) :207-211
[2]   IMPORTANCE OF BLOOD-FLOW TO THE LOCAL-DISTRIBUTION OF DRUGS AFTER PERCUTANEOUS-ABSORPTION IN THE BIPEDICULATED DORSAL FLAP OF THE HAIRLESS RAT [J].
AUCLAIR, F ;
BESNARD, M ;
DUPONT, C ;
WEPIERRE, J .
SKIN PHARMACOLOGY, 1991, 4 (01) :1-8
[3]  
Barry B.W., 2002, Pharmaceutics: The Science of Dosage Form Design, V2nd ed., P499
[4]   Novel mechanisms and devices to enable successful transdermal drug delivery [J].
Barry, BW .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 14 (02) :101-114
[5]   INTRAVENOUS NICOTINE RETARDS TRANSDERMAL ABSORPTION OF NICOTINE - EVIDENCE OF BLOOD-FLOW LIMITED PERCUTANEOUS-ABSORPTION [J].
BENOWITZ, NL ;
JACOB, P ;
OLSSON, P ;
JOHANSSON, CJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (03) :223-230
[6]  
CATTERALL W, 1995, GOODMAN GILMANS PHAR, P331
[7]  
CROSS SE, 1997, LANCET, V350, P363
[8]   THE DISPOSITION OF BIPHENYLACETIC ACID FOLLOWING TOPICAL APPLICATION [J].
DAWSON, M ;
MCGEE, CM ;
VINE, JH ;
NASH, P ;
WATSON, TR ;
BROOKS, PM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 33 (06) :639-642
[9]   Estimation of intradermal disposition kinetics of drugs: II. Factors determining penetration of drugs from viable skin to muscular layer [J].
Higaki, K ;
Asai, M ;
Suyama, T ;
Nakayama, K ;
Ogawara, K ;
Kimura, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 239 (1-2) :129-141
[10]  
Higaki K., 2003, Am. J. Drug Delivery, V1, P187